Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 352 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

for
Ovarian Cancer, Fallopian Tube Carcinoma, Ovarian Carcinoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06290193

Phase2, Recruiting

Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer

for
Ovarian Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05636111

Phase1, Recruiting

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

for
Advanced Solid Tumor, Ovarian Cancer, Endometrial Cancer, NSCLC
Location: New York NY, Fairfax VA, Cleveland OH, Lexington KY,
Sponsor: TORL Biotherapeutics, LLC

Sex: All

Age: 18+

Code: NCT05103683

Phase1, Recruiting

Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro

for
Ovarian Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: Female

Age: 18+

Code: NCT05952453

Phase2, Recruiting

Study of AVZO-021 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor, HR+/HER2- Breast Cancer,
Location: New Haven CT, Mineola NY, New York NY, Philadelphia PA,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05867251

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

for
Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Boston MA, Providence RI, New York NY, Durham NC,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female

Age: 18+

Code: NCT04516447

Phase1, Recruiting

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

for
Breast Cancer, Gastric Cancer, Esophageal Cancer,
Location: New York NY, Nashville TN, Houston TX, Dallas TX,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06695845

Phase2, Recruiting

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

for
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: Female

Age: 18+

Code: NCT04701645

Phase1, Recruiting

A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery

for
Peritoneal Carcinomatosis, Ovarian Cancer
Location: Tampa FL
Sponsor: Oncoinvent Solutions AS

Sex: Female

Age: 18+

Code: NCT06504147

Phase2, Recruiting

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

for
Ovarian Cancer Recurrent
Location: Boston MA, New Haven CT, New York NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06843447

Phase1, Phase2, Recruiting

Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients

for
Ovarian Cancer, Epithelial Ovarian Cancer,
Location: Kansas City KS
Sponsor: Andrea Jewell

Sex: Female

Age: 18+

Code: NCT03321188

Phase2, Recruiting

Lead-212 PSV359 Therapy for Patients With Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Gastric Cancer,
Location: Miami FL, Pittsburgh PA, Columbus OH, Lexington KY,
Sponsor: Perspective Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06710756

Phase1, Phase2, Recruiting

A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

for
Platinum-resistant Ovarian Cancer
Location: Newport Beach CA, El Segundo CA
Sponsor: ImmunityBio, Inc.

Sex: Female

Age: 18 - 70+

Code: NCT06710288

Phase2, Recruiting

13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.

for
Ovarian Cancer, Ascites
Location: Victoria
Sponsor: British Columbia Cancer Agency

Sex: Female

Age: 18+

Code: NCT05025878

Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Boston MA, New York NY, Paramus NJ, Bethlehem PA,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase3, Recruiting

CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer

for
Recurrent Ovarian Cancer
Location: Pittsburgh PA
Sponsor: Lan Coffman

Sex: Female

Age: 18+

Code: NCT05942300

Phase1, Recruiting

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

for
Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06855706

Recruiting

Patient Preferences for Precision Medicine: Determining Optimal Patient Quality of Life Using PARPi's

for
Ovarian Cancer, Quality of Life
Location: Saskatoon
Sponsor: University of Saskatchewan

Sex: Female

Age: 0+

Code: NCT06751303

Recruiting

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

for
Ovarian Cancer, Malignant Neoplasm of Uterus
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: Female

Age: 18+

Code: NCT06040970

Phase1, Phase2, Recruiting

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Scarborough ME, Providence RI, Commack NY, Norwalk CT,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06580314

Phase3, Recruiting